Connect with us

Cannabis News

Indiana GOP Governor Directs State Agencies To Meet With Medical Marijuana Advocates As Federal Rescheduling Takes Effect

Published

1 month ago

on

Indiana state officials are holding a series of meetings with medical marijuana advocates at the behest of the Republican governor.

After a day The Trump administration announced that federal cannabis regulation is moving forwardOfficials from the Indiana Department of Veterans Affairs, Department of Health and other state agencies spoke with Hoosier Veterans for Medical Cannabis and Indiana NORML to discuss next steps at the state level.

The meetings, activists said, were at the request of Gov. Mike Braun (R).

“The governor has reached out to us to meet with other heads of his department to get their input on this move,” military veteran Jeff Staker, one of the advocates, told Fox 59. “Our next step, hopefully, will be in the governor’s office.”




Lucy Luman, who is also a veteran and serves as president of Indiana NORML, he said That federal reform “addresses major challenges our lawmakers have raised before.”

Advocates previously met with Indiana Secretary of Business Affairs Mike Speedy, they told WHTR-TV.

“It tells you that the governor has considered it well, and I hope that our organization and others will come into the governor’s office and discuss with him and brainstorm more,” Staker. he said. “You have to realize that a lot of our state legislators have been waiting for that to happen.”

“The feds have made their move, and now it’s time for Indiana to make ours,” he said. “And of course we want to do well.”




State Rep. Jim Lucas (R) said federal marijuana rescheduling “takes away the arguments that the opposition had in our state.”

State Sen. Rodney Pol (D) agreed, saying the Trump administration’s action has “helped get the ball rolling.”

last month, The governor said the “crescendo will rise” in the call to legalize marijuanaregional dynamics as well as law enforcement by opting for reform. But for now, he said, the GOP legislative leadership is “not interested in doing anything anytime soon,” even though “half of Hoosiers probably smoke illegally.”

Braun said he thinks lawmakers should take an “extra look” at medical cannabis and, while he’s personally “agnostic” about legalization, the reality is Indiana is “now surrounded by four states” that allow medicinal or adult use of cannabis.

“Probably half of Hoosiers smoke illegally,” he said, noting that suburban Kentucky allows patients to access medical cannabis, while Illinois, Michigan and Ohio have recreational marijuana laws.

“I’m going to listen to law enforcement. They’ve even changed their minds about legalizing and regulating,” Braun said, adding that he compared cannabis to gambling. The state was late to pass laws allowing adults to gamble, he said, but now ranks among the top three states nationally in terms of per capita revenue from vice.

“Some people won’t want to, just on principle. A lot of police and sheriffs in our state are willing to cross the border (to buy cannabis). It’s going to be a growing problem, so far, the way our state legislature has opposed it,” he said. “I’ve been more agnostic about it. I can see the points of view, and I’ve seen law enforcement move somewhat.”

“So that will give you the best description of where the dynamic is in our state,” the governor told WOWO. “I think the leader of the Senate and the Speaker of the House in particular are cool — and they control the legislative agenda — they’re not interested in doing anything anytime soon. But I think the crescendo will rise, and that pretty much describes where we are.”

Braun also addressed the issue in another recent interview, saying the state will “probably have to address” the issue and pairing cannabis reform with sports betting.

State legislators already He stated that there is no legalization of marijuana in the 2026 sessionThis is another year where Indiana will be left out as one of the few states without effective medical or adult use cannabis laws.

The governor said this separately in January He “fits in” with the idea of ​​legalizing medical cannabis in the state. Instead, Indiana lawmakers this session have focused on efforts to ban THC hemp products, though The fight for 2026 appears to be over after a last-minute push failed late last month.

Braun has previously said that federal marijuana reorganization He could add “some fire” to the local push to legalize cannabis in his state.

Among Indiana residents, a survey released in January found that nearly three in five supported the legalization of medical and recreational cannabis.

Specifically, Ball State University’s (BSU) Bowen Center’s annual Hoosier Poll found that 59 percent of residents support the legalization of cannabis for medical and recreational purposes. An additional 25 percent return allowing patients to access medical marijuana, bringing total support for that reform to 84 percent.

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Braun, for his part, He previously said it is “probably time” to introduce therapeutic cannabis among state patients. The comments came alongside a separate poll showing that nearly 9 in 10 Indiana adults (87 percent) support the legalization of marijuana.

The main Republicans in the Legislature, however, They have openly opposed marijuana reform.

“It’s no secret that I’m not,” Senate President Pro Tem Rodric Bray (R) said at the end of 2024. “I don’t have people coming to me with really compelling medical cases to find out why it’s so beneficial. And any situation I’ve seen, it’s passing medical marijuana, it’s basically passing recreational marijuana.”

House Speaker Todd Huston (R) questioned any medical benefits associated with marijuana, calling the substance a “mental health deterrent.” He and others suggested that lawmakers in favor of reform simply want to increase state revenue.

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Related Topics:
Continue Reading

Cannabis News

Concert Series Specials launched for state medical cannabis patients

Published

10 hours ago

on

June 8, 2026

By











Post Dispensary, Kentucky’s first medical cannabis dispensary, is connecting with patients in Owensboro, Henderson, Bowling Green, Elizabethtown, Madisonville, Hopkinsville and surrounding areas by aligning unique specials with the region’s summer concert calendar. Located at 300 N Main St. in Beaver Dam, minutes from major highways connecting these vibrant cities.

This summer, The Post Dispensary is offering special pricing and incentives for Concert Series Events at the Beaver Dam Amphitheater, SPARKS in the Park 4th of July celebration and surrounding events, such as Owensboro’s ROMP Festival (June 24-27, 2026). Patients can stop by before or after shows for big savings.

“We’re more than just a booty,” said a dispensary representative. “From Owensboro’s world-class ROMP Festival to Beaver Dam’s Amphitheater events, we’re making it convenient and budget-friendly for patients in Owensboro, Henderson, Bowling Green, Elizabethtown, Hartford and beyond to combine our love of music with compassionate care and an affordable product.”

The Post Dispensary hosts regular Patient Guidance events on the second Saturday of every month. These units have professionals on hand to assess patients and issue written certificates at low cost, application support and expert consultations in a welcoming environment. The next Patient Drive aligns perfectly with summer travel patterns, making it easy for patients from Owensboro, Bowling Green, Elizabethtown, Madisonville, Henderson, Madisonville and surrounding towns to plan a trip to Beaver Dam that combines care with community and entertainment.

For more information:
Post-Dispensary
thepostdispensary.com/










Continue Reading

Cannabis News

Missouri GOP Lawmakers Hope Trump’s Psychedelics Order Boosts Efforts To Allow Military Veteran Access In The State

Published

10 hours ago

on

June 8, 2026

By

“Congratulations to President Trump for stepping up and taking the lead on this. PTSD is a killer among veterans.”

By Rebecca Rivas, Missouri Independent

Missouri state representative Dave Griffith has spent the past five years researching how psychedelic-assisted therapy has helped veterans struggling with post-traumatic stress disorder and depression.

His last legislative session in the House ended this May, and he pushed legislation for the last time allow clinical trials of psychedelic-assisted therapy in Missouri. In the final days of the session, the bill stalled in the Missouri Senate after passing the House with overwhelming support.

“I’m not going to be there next year, I’m term-limited,” said Griffith, a Republican who served as chairman of the House Veterans Affairs and Armed Services Committee. “It’s really about passing the torch to a lot of other veterans who are on the Veterans Commission and see the value in that.”

He was hopeful when he saw an announcement The US Department of Veterans Affairs announced last week a new clinical trial to evaluate the safety and effectiveness of methylenedioxymethamphetamine-assisted therapy.or MDMA-assisted therapy. MDMA is a synthetic substance made in a laboratory, according to the department, and is also called “ecstasy” or “molly” in recreational use.

“Congratulations to President Trump for stepping up and taking the lead on this,” said Griffith of Jefferson City. “PTSD is a killer among veterans. If you just listen to the testimony that’s been happening over the last five years in the Missouri House, the life-changing it’s been for them is a compelling reason why something like this works.”

A new trial follows Trump signed an executive order in April, “Expediting Medical Treatment for Serious Mental Illness.” The order aims to increase participation in clinical trials and accelerate innovative research models and drug approvals for psychedelics.

Directs the Secretary of Health and Human Services to allocate at least $50 million to support and collaborate with state governments that “have established or are developing programs to advance psychedelic drugs for serious mental illness.”

Without passing the legislation, Missouri will miss this opportunity, said Republican state representative Matthew Overcast of Ava.

Cloud hoped that Trump’s April order would help “grease the wheels” this year by state Rep. Richard West and state Rep. Richard West who sponsored the state to conduct a study on psilocybin and ibogaine therapy.

“The last couple of months there’s been a lot of feds on things that the states are reluctant to move forward with here,” Overcast said. “So it’s exciting.”

According to the VA’s announcement, the department is involved in 19 other active clinical trials focused on psychedelic therapies for mental health conditions that have received more than $23 million in outside funding.

The new trial, called “A Randomized Controlled Trial of MDMA-Assisted Therapy for PTSD and Alcohol Use Disorder in US Veterans,” will enroll about 80 veterans and compare outcomes between those receiving MDMA-assisted therapy and those receiving the same psychotherapy with an active placebo. VA is coordinating with the US Food and Drug Administration and plans to share trial data with FDA.

The trial will be conducted at the VA Providence Healthcare System, and will recruit veterans from the Providence, Rhode Island, campus in West Haven, Connecticut, and the VA Connecticut Healthcare System.

Trump’s executive order says there have been more than 6,000 veteran suicides per year for more than 20 years, and the current veteran suicide rate is twice that of the adult non-veteran population.

He says people with major depressive disorder and substance abuse disorder, among other serious mental illnesses, may relapse or fail to respond fully to standard medical and psychiatric therapies.

“Despite significant federal investment in research into potential advances in mental health care and treatment, our medical research system has yet to produce approved therapies that promote lasting improvements in the mental health status of the most complex patients,” the order states. “Innovative methods are needed to find long-term solutions for these Americans beyond existing prescription drugs.”

Missouri veterans John and Kara Grady, who own a hemp shop in Rosebud, strongly agree with the statement, they said. And they’d like to see Missouri’s veterans health system participate in clinical trials already underway.

“President Trump is opening up investigations for the veteran community,” said John Grady, “If you look at the numbers … we’ve lost more in the wars with mental health than we’ve lost.”

The lack of movement on psychedelic-assisted therapy legislation is among the reasons why John Grady is running for state representative over Bruce Sassmann in the state’s Republican primary.

“If you don’t agree with Trump on everything, at least he’s addressing this veteran issue right here,” Grady said. “Hopefully, we’ll be able to stop that number, we’ll stop that flow of our precious veterans dying by their own hands because they don’t have treatment.”

This story was first published by the Missouri Independent.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Germany’s medical cannabis imports post first quarterly decline since early 2024

Published

1 day ago

on

June 7, 2026

By

German imports of medical cannabis flowers fell to 50.5 tonnes in the first quarter of 2026, down from 60.8 tonnes in the previous quarter, the decline from the first quarter of 2024. According to a new EU and UK market update from Whitney Economics.

The drop lands against a year that went backwards. Germany took in more than 2025 tonnes of the product in 2025, more than double the 72,850 kilograms recorded in 2024, and import volumes have risen every year since 2018, when the figure remained below 4,500 kilograms. The first quarter number continues to match the high pace of 2025, which is why the report treats it as an early sign of stabilization rather than a turnaround.

Prices
The volume has not created a stable price. A gram of cannabis in a German pharmacy is approaching 4 euros, while a gram on the illegal market is around 8 euros, reversing the usual relationship between regulated and unregulated supply. The wholesale price is around 2 euros per gram, roughly half the retail price at the pharmacy. Pharmacy prices breached 3.99 euros in November 2025, and the report puts the overall compression close to 25% in two and a half years.

Germany legalized ownership in 2024 and restricted sales to pharmaceutical and telemedicine providers. Two access roads run parallel. Medical cannabis is mainly prescribed through private prescriptions, and recreational cannabis is available through membership of a cannabis association, with 400 licensed cultivation associations across the country, although the exact count varies by source. It is the medical segment that drives market growth, not the recreational segment.

Growth is based on telemedicine
 Patients fill out an online questionnaire, receive a prescription from an affiliated physician, and in many cases have their order filled through an integrated pharmacy partner, with delivery within days and, in some cities, within hours. Between 600,000 and 700,000 self-employed consumers are supported by the telemedicine industry, compared to 200,000 to 300,000 medical patients supported by pharmacies. Total imports are now sufficient to supply between 900,000 and one million consumers.

© Philiprowe | Dreamstime

Market exposure
Critics argue that commercial interests risk overshadowing the medical nature of the system, and treatment does not always meet the required standard of control. Legislative initiatives that would tighten the framework are already on the table, including mandatory in-person inquiries and a ban on distribution of mail requests. The likely result of both measures is a significant decline in demand for medical cannabis flowers. Many telemedicine companies are preparing for the opportunity by building networks with local doctors and pharmacies.

Where patients and consumers would go if medical access is curtailed is an open question, as the recreational market lacks a real alternative for patients and cannabis clubs continue to face licensing hurdles at the state level.

Part of the difficulty in reading the market is that import figures say less than they seem. More cannabis is entering the country than ever before, but how much is reaching consumers and what the actual demand is is unclear. Without a nationwide data framework, the market functions as a black box, and excess supply and actual demand are difficult to measure with great precision. Supply has tended to expand faster than the market can absorb, with no forecast to confirm mature demand, and prices have adjusted downward as a result.

Germany has had a signal effect across Europe since the start of its reform, although its model has drawn criticism, with the mixing of medical and recreational consumption a recurring complaint. Countries that have traditionally taken a conservative line, France among them, have gone to a more formalized medical field, under stricter conditions and without adopting the medical flower like Germany.

For more information:
Whitney Economics
Beau Whitney
(503) 724-3084
www.whitneyeconomics.com

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media